They also had a higher frequency dyspnea, cough, fever, nausea, and arthralgia; clinical findings such as fever, tachycardia and arterial hypotension (Supplementary Table S4) and laboratory findings such as neutrophilia, lymphopenia, thrombocytopenia and increased lactate, D-dimer and C-reactive protein, when compared to those who did not receive IMV (Supplementary Tables S4, S5). This evidence concerns the gene CRP and lymphopenia.